Biotech Startups

1 investor

Magmatic designs and builds custom synthetic proteins that selectively bind and separate metals from complex mixtures, using an AI-powered bioengineering platform. Its biorefining process targets critical minerals such as lithium, rare earth elements, nickel, and manganese, serving the critical minerals supply chain and material recycling from batteries and electronic waste.

1 investor

Magnendo develops a magnetically steerable soft-robotic guidewire system for neurovascular endovascular procedures, enabling physicians to access hard-to-reach targets in the brain's blood vessels for stroke and aneurysm treatment. The system is designed to reduce procedural time, complications, and costs while improving patient outcomes.

1 investor

1 investor

1 investor

A company using artificial intelligence to identify natural proteins of interest, operating at the intersection of foodtech, immunology, and biotech.

1 investor

MAIA Biotech is a clinical-stage biopharmaceutical company developing telomere-targeting cancer therapies, with a lead compound (THIO) based on a telomerase-targeting therapeutic approach. Its work spans oncology and nucleic acid-based therapeutics across multiple tumor types.

1 investor

Manna Molecular develops cannabis and CBD products using scientific methods, creating transdermal patches, serums, lotions, and delivery systems for precise dosing and personalized therapy.

1 investor

MantaBio builds an automated contamination and sterility testing platform for the drug supply chain, using a closed single-cartridge automated vPCR workflow (the MantaVision Automated vPCR Platform) for release and in-process microbial detection. It serves biopharma manufacturers, CDMOs, and clinical sites, deployable from the bioreactor floor to point-of-care manufacturing sites.

1 investor

MapLight develops neurological and neuropsychiatric drug therapies using a discovery platform that identifies neural circuits linked to disease for targeted treatment of conditions like schizophrenia, Alzheimer's disease psychosis, and autism spectrum disorder.

1 investor

MAPS is a nonprofit organization founded in 1986 that conducts research, education, and advocacy on psychedelic-assisted therapy and drug policy reform, including clinical studies of MDMA-assisted therapy. It also supports harm reduction and peer support through the Zendo Project, aiming to end psychedelic prohibition and make psychedelics and marijuana legally available for beneficial uses.

1 investor

MARAbio is a precision immunology company developing blood tests to identify Maternal Autoantibody Related Autism (MARA), a subtype estimated to represent up to 20% of autism diagnoses, alongside companion diagnostics and therapeutic antibody interventions for early detection and targeted treatment.

1 investor

MARAbio develops a blood test for mothers that detects Maternal Autoantibody Related Autism (MARA) by identifying a cluster of antibodies, aiming to predict the likelihood of MARA in a child before clinical symptoms appear. The company is also researching therapeutic interventions for MARA.

1 investor

Maracorp produces fish-free Omega-3 supplements derived from algae for human health and nutrition. The company focuses on sustainable, plant-based alternatives to fish oil for consumer wellness.

1 investor

Marco transforms discarded coffee grounds from Parisian offices into cosmetic ingredients and biomaterials using supercritical CO2 extraction and green chemistry processes. The company produces natural cosmetic actives (OILCO, BUTTERCO, MARCO) with complete supply chain traceability and reduced carbon footprint.

1 investor

Marengo Therapeutics is a clinical-stage biotech company developing TCR-targeting antibodies that activate specific T cell subsets by targeting Variable β (Vβ) chain variants of the T cell receptor. Its approach aims to modulate the immune system to treat cancer and other diseases.

1 investor

1 investor

Marinexcell develops cultivated shrimp, lobster, and crab meat with taste, texture, and nutritional profiles matching wild-caught seafood, eliminating overfishing, pollution, antibiotics, and animal suffering. The company produces genuine shellfish meat through sustainable, climate-positive practices.

1 investor

Marksans Pharma is an Indian pharmaceutical company that researches, manufactures, and markets finished dosage pharmaceutical formulations. Its portfolio spans over-the-counter consumer self-care products and prescription (Rx) therapeutic segments, sold across global markets.

1 investor

Martínez Nieto manufactures and distributes nutritional supplements, vitamins, cosmetics, essential oils, and cosmeceuticals for sale across more than 70 countries. The company operates one of the largest production facilities in Europe with a focus on quality control, sustainability, and premium product standards.

1 investor

MarvelBiome is a clinical-stage biotechnology company developing Live Biotherapeutic Products through engineered bacterial consortia designed to treat disease-specific conditions. The company focuses on microbiome-based treatments for patients.

1 investor

MaRVis develops MR-safe medical devices, particularly guidewires and catheters, designed to enable MRI-guided minimally invasive surgical procedures in cardiology, oncology, and vascular interventions. The company's proprietary materials allow visualization and safe operation of these devices within MRI environments without radiation exposure.

1 investor

MasterControl provides an integrated software platform for life sciences manufacturers that combines quality management, manufacturing execution, and asset management with built-in AI and business intelligence capabilities.

1 investor

MasterMediTech is a drug-discovery venture company that develops new drug candidates using protein structure analysis and medicinal chemistry. It operates in the biotech and pharmaceutical research sector.

1 investor